In vitro antimicrobial susceptibility of Staphylococcus pseudintermedius isolates of human and animal origin Academic Article uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Staphylococcal Infections
  • Staphylococcus intermedius

abstract

  • MIC results for 115 Staphylococcus intermedius group isolates are presented. Of these, 33% were methicillin resistant, among which 51.4% were susceptible to doxycycline, 29.7% to clindamycin, and 21.6% to trimethoprim-sulfamethoxazole. All of the isolates were susceptible to ceftaroline, daptomycin, linezolid, nitrofurantoin, quinupristin-dalfopristin, rifampin, tigecycline, and vancomycin. Of all the isolates, 82.6%, 67.8%, and 23.5% were susceptible to ciprofloxacin, erythromycin, and penicillin, respectively. No isolates harbored mupA or qacA/B genes, which suggested a lack of resistance to mupirocin or chlorhexidine.

publication date

  • May 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4844724

Digital Object Identifier (DOI)

  • 10.1128/JCM.00270-16

PubMed ID

  • 26962087

Additional Document Info

start page

  • 1391

end page

  • 4

volume

  • 54

number

  • 5